(Q40738827)

23 September 2017

AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers (English)

1 reference

23 September 2017

1 reference

Kazumi Suzukawa

1

1 reference

23 September 2017

Nancy H Colburn

series ordinal

2

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

23 September 2017

1 reference

23 September 2017

21

1 reference

23 September 2017

2181-2190

1 reference

23 September 2017

14

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205281

23 September 2017

0 references

cites work

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Function and regulation of AP-1 subunits in skin physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Histone deacetylases: transcriptional repression with SINers and NuRDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

12-O-tetradecanoylphorbol-13-acetate--induced levels of AP-1 proteins: a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Tumor promotion resistant cells are deficient in AP-1 DNA binding, JunD DNA binding and JunD expression and form different AP-1-DNA complexes than promotion sensitive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

The histone acetylase PCAF is a nuclear receptor coactivator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Retinoids in cancer prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

A transcriptional co-repressor that interacts with nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Tumour promoter induces anchorage independence irreversibly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Retinoids inhibit promoter-dependent preneoplastic progression in mouse epidermal cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Identification of the AP1-antagonism domain of retinoic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

A new class of retinoids with selective inhibition of AP-1 inhibits proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Characterization of retinoic acid receptor-deficient keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-alpha but not by 12-O-tetradecanoylphorbol-13-acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

The role of gene dosage and genetic transpositions in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Therapeutic potential of selective modulators of nuclear receptor action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Extracellular signal-regulated kinase 1/2-mediated phosphorylation of JunD and FosB is required for okadaic acid-induced activator protein 1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Correlation of the ability of retinoids to inhibit promoter-induced anchorage-independent growth of JB6 mouse epidermal cells with their activation of retinoic acid receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Retinoic acid is a negative regulator of AP-1-responsive genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Conserved motifs in Fos and Jun define a new class of activation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

7 January 2021

AP-1/jun is required for early Xenopus development and mediates mesoderm induction by fibroblast growth factor but not by activin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

7 January 2021

Changes in keratin gene expression during terminal differentiation of the keratinocyte

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

7 January 2021

Enhancing effect of tumor promoters, phorbol esters and teleocidins on nuclear receptor-mediated transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

7 January 2021

Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

7 January 2021

Nuclear receptor/AP-1 interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

7 January 2021

Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

7 January 2021

Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205281

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205281

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference